Hi George,
We don’t know, but they are new sub-analyses being presented by Janssen from the CREDENCE trial. PIQ were looking at CKD & whether PromarkerD can predict cardiovascular disease also from past ANNs.
Here is the link where you can view slides from presentations & they will come out after they are presented (as per times & dates in your post).
https://www.acc.org/latest-in-cardiology/features/meeting-coverage/2020/acc-2020-meeting-coverage
There may be some clues there, I really hope so.
Regarding Janssen presentation this weekend., page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
-0.020(6.15%) |
Mkt cap ! $49.87M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.5¢ | 28.5¢ | $201.7K | 642.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3253 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 57411 | 2 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |